Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Eli Lilly and Company
Sun Yat-sen University
Eli Lilly and Company
Emory University
Pfizer
Bayer
Eli Lilly and Company
Dana-Farber Cancer Institute
AstraZeneca
Eli Lilly and Company
Columbia University
Masonic Cancer Center, University of Minnesota
University of Washington
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Mayo Clinic
NYU Langone Health